Rule 15c3-1f (Appendix F to Rule 15c3-1), Optional Market and Credit Risk Requirements for OTC Derivatives Dealers

ICR 201902-3235-029

OMB: 3235-0496

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2019-05-21
Supplementary Document
2019-02-21
Supplementary Document
2019-02-21
ICR Details
3235-0496 201902-3235-029
Active 201512-3235-018
SEC TM-270-440
Rule 15c3-1f (Appendix F to Rule 15c3-1), Optional Market and Credit Risk Requirements for OTC Derivatives Dealers
Extension without change of a currently approved collection   No
Regular
Approved without change 07/12/2019
Retrieve Notice of Action (NOA) 05/21/2019
  Inventory as of this Action Requested Previously Approved
07/31/2022 36 Months From Approved 07/31/2019
7 0 6
6,000 0 5,000
0 0 0

Appendix F provides an alternative net capital requirement and method for determining net capital for a class of dealers active in over-the-counter markets called OTC derivatives dealers. Rule 15c3-1 is intended to ensure that broker-dealers have sufficient capital to protect the assets of customers and to meet their responsibilities to other participants in the financial markets. The rule facilitates the monitoring of the financial condition of securities broker-dealers by the Commission and the various self-regulatory organizations.

US Code: 15 USC 78c, 78d, 78i, 78j, 78l, 78m, Name of Law: Securities Exchange Act of 1934
  
None

Not associated with rulemaking

  84 FR 6451 02/27/2019
84 FR 19986 05/07/2019
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 7 6 0 0 1 0
Annual Time Burden (Hours) 6,000 5,000 0 0 1,000 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
The Commission now estimates that a total of six OTC derivatives dealers will be approved to use appendix F within the next three years, consisting of the three broker-dealers currently approved, the two broker-dealers with pending applications, and one additional broker-dealer expected to apply. The Commission previously estimated that a total of five entities would be approved to use appendix F at the end of three years, consisting of four current OTC derivatives dealers and one anticipated applicant.

$0
No
    No
    No
No
No
No
Uncollected
Rose Wells 202 942-0143

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
05/21/2019


© 2024 OMB.report | Privacy Policy